| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 764424 | 1221652004 | FILSUVEZ GEL | FILSUVEZ GEL, 30 tubos de 23,4 g | 100 mg/g | 44 | 23,4 | 21 | 30 tubos de 23,4 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1221652004/1221652004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221652004/1221652004_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 19683 | CHIESI ESPAÑA S.A.U. | 2024-02-27 | 1 | 1 | 1 | 2024-02-28 | 2024-02-27 | 0 | 2024-10-09 | View Edit Delete | ||||||||||||
| 758636 | 1221655011 | PIRFENIDONA AXUNIO 267 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PIRFENIDONA AXUNIO 267 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 252 comprimidos | 267 mg | 5 | 252 | 10 | 252 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1221655011/1221655011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221655011/1221655011_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27750 | LABORATORIOS RODIO S.L. | 2022-10-14 | 1 | 1 | 1 | 2022-10-15 | 2022-10-14 | 1 | 2022-12-27 | View Edit Delete | ||||||||||||
| 758635 | 1221655013 | PIRFENIDONA AXUNIO 801 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PIRFENIDONA AXUNIO 801 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 84 comprimidos | 801 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1221655013/1221655013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221655013/1221655013_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27750 | LABORATORIOS RODIO S.L. | 2022-10-14 | 1 | 1 | 1 | 2022-10-15 | 2022-10-14 | 1 | 2022-12-27 | View Edit Delete | ||||||||||||
| 758538 | 1221657001 | KINPEYGO 4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA | KINPEYGO 4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA, 120 capsulas | 4 mg | 6 | 120 | 43 | 120 capsulas | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221657001/1221657001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221657001/1221657001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2787 | LABORATORIO STADA S.L. | 2022-10-14 | 1 | 1 | 1 | 2022-10-15 | 2022-10-14 | 1 | 2025-06-11 | View Edit Delete | ||||||||||||
| 758350 | 1221658001 | GANIRELIX GEDEON RICHTER 0,25 MG/0,5 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG | GANIRELIX GEDEON RICHTER 0,25 MG/0,5 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG, 1 jeringa precargada | 0,25 mg inyectable 0,5 ml | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1221658001/1221658001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221658001/1221658001_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8334 | GEDEON RICHTER IBERICA S.A. | 2022-10-05 | 1 | 1 | 1 | 2022-10-06 | 2022-10-05 | 1 | 2023-03-09 | View Edit Delete | ||||||||||||
| 758351 | 1221658001 | GANIRELIX GEDEON RICHTER 0,25 MG/0,5 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG | GANIRELIX GEDEON RICHTER 0,25 MG/0,5 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG, 6 jeringas precargadas | 0,25 mg inyectable 0,5 ml | 33 | 6 | 61 | 6 jeringas precargadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1221658001/1221658001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221658001/1221658001_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8334 | GEDEON RICHTER IBERICA S.A. | 2022-10-05 | 1 | 1 | 1 | 2022-10-06 | 2022-10-05 | 1 | 2023-03-09 | View Edit Delete | ||||||||||||
| 758015 | 1221659001 | XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 20 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221659001/1221659001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221659001/1221659001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 42448 | SANOFI AVENTIS S.A. | 2022-07-29 | 1 | 1 | 1 | 2022-07-30 | 2022-07-29 | 1 | 2024-05-14 | View Edit Delete | ||||||||||||
| 762543 | 1221659005 | XENPOZYME 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | XENPOZYME 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 4 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221659005/1221659005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221659005/1221659005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 42448 | SANOFI AVENTIS S.A. | 2023-05-04 | 1 | 1 | 1 | 2023-05-05 | 2023-05-04 | 1 | 2024-05-14 | View Edit Delete | ||||||||||||
| 758314 | 1221663001 | SUGAMMADEX FRESENIUS KABI 100 MG/ML SOLUCION INYECTABLE EFG | SUGAMMADEX FRESENIUS KABI 100 MG/ML SOLUCION INYECTABLE EFG, 10 viales de 2 ml | 100 mg/ml inyectable 2 ml | 45 | 10 | 34 | 10 viales de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1221663001/1221663001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221663001/1221663001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2022-10-06 | 1 | 1 | 1 | 2022-10-07 | 2022-10-06 | 1 | 2023-07-12 | View Edit Delete | ||||||||||||
| 758315 | 1221663001 | SUGAMMADEX FRESENIUS KABI 100 MG/ML SOLUCION INYECTABLE EFG | SUGAMMADEX FRESENIUS KABI 100 MG/ML SOLUCION INYECTABLE EFG, 10 viales de 5 ml | 100 mg/ml inyectable 5 ml | 45 | 10 | 34 | 10 viales de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1221663001/1221663001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221663001/1221663001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2022-10-06 | 1 | 1 | 1 | 2022-10-07 | 2022-10-06 | 1 | 2023-07-12 | View Edit Delete | ||||||||||||
| 759296 | 1221664001 | CEVENFACTA 1 MG (45 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CEVENFACTA 1 MG (45 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de polvo y 1 jeringa precargada de disolvente | 1 mg (45.000 UI) | 45 | 1 | 34 | 1 vial de polvo y 1 jeringa precargada de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221664001/1221664001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221664001/1221664001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | LFB BIOTERAPIAS HISPANIA S.L. | 2023-01-09 | 1 | 1 | 1 | 2023-01-10 | 2023-01-09 | 1 | 2023-04-03 | View Edit Delete | ||||||||||||
| 759310 | 1221664002 | CEVENFACTA 2 MG (90 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CEVENFACTA 2 MG (90 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de polvo y 1 jeringa precargada de disolvente | 2 mg (90.000 UI) | 45 | 1 | 34 | 1 vial de polvo y 1 jeringa precargada de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221664002/1221664002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221664002/1221664002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | LFB BIOTERAPIAS HISPANIA S.L. | 2023-01-09 | 1 | 1 | 1 | 2023-01-10 | 2023-01-09 | 1 | 2023-04-03 | View Edit Delete | ||||||||||||
| 759311 | 1221664003 | CEVENFACTA 5 MG (225 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CEVENFACTA 5 MG (225 KIU) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de polvo y 1 jeringa precargada de disolvente | 5 mg (225.000 UI) | 45 | 1 | 34 | 1 vial de polvo y 1 jeringa precargada de disolvente | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221664003/1221664003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221664003/1221664003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 39932 | LFB BIOTERAPIAS HISPANIA S.L. | 2023-01-09 | 1 | 1 | 1 | 2023-01-10 | 2023-01-09 | 1 | 2023-04-03 | View Edit Delete | ||||||||||||
| 758486 | 1221667001 | VEGZELMA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | VEGZELMA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 25 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221667001/1221667001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221667001/1221667001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | CELLTRION FARMACÉUTICA (ESPAÑA) S.L. | 2022-10-05 | 1 | 1 | 1 | 2022-10-06 | 2022-10-05 | 1 | 2022-12-13 | View Edit Delete | ||||||||||||
| 758487 | 1221667001 | VEGZELMA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | VEGZELMA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 16 ml | 25 mg/ml inyectable 16 ml | 45 | 1 | 34 | 1 vial de 16 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221667001/1221667001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221667001/1221667001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | CELLTRION FARMACÉUTICA (ESPAÑA) S.L. | 2022-10-05 | 1 | 1 | 1 | 2022-10-06 | 2022-10-05 | 1 | 2022-12-13 | View Edit Delete | ||||||||||||
| 762859 | 1221669001 | PEPAXTI 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | PEPAXTI 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 20 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1221669001/1221669001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221669001/1221669001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 43589 | ONCOPEPTIDES AB | 2023-09-11 | 1 | 1 | 1 | 2023-09-12 | 2023-09-11 | 1 | 2024-04-15 | View Edit Delete | ||||||||||||
| 758215 | 1221670002 | SCEMBLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SCEMBLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 20 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221670002/1221670002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221670002/1221670002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2022-10-06 | 1 | 1 | 1 | 2022-10-07 | 2022-10-06 | 1 | 2023-11-27 | View Edit Delete | ||||||||||||
| 758216 | 1221670004 | SCEMBLIX 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SCEMBLIX 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 40 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221670004/1221670004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221670004/1221670004_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2022-10-06 | 1 | 1 | 1 | 2022-10-07 | 2022-10-06 | 1 | 2023-11-27 | View Edit Delete | ||||||||||||
| 758207 | 1221671001 | SUNLENCA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SUNLENCA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 5 comprimidos | 300 mg | 5 | 5 | 10 | 5 comprimidos | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221671001/1221671001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221671001/1221671001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16632 | GILEAD SCIENCES S.L. | 2022-09-16 | 1 | 1 | 1 | 2022-09-17 | 2022-09-16 | 1 | 2024-06-13 | View Edit Delete | ||||||||||||
| 758208 | 1221671002 | SUNLENCA 464 MG SOLUCION INYECTABLE | SUNLENCA 464 MG SOLUCION INYECTABLE, 2 viales de 1,5 ml | 464 mg | 45 | 2 | 34 | 2 viales de 1,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221671002/1221671002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221671002/1221671002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16632 | GILEAD SCIENCES S.L. | 2022-09-16 | 1 | 1 | 1 | 2022-09-17 | 2022-09-16 | 0 | 2024-06-13 | View Edit Delete |
Page 127 of 1036, showing 20 records out of 20703 total, starting on record 2521, ending on 2540